People Bereaved by Violent Death : Negative Event Biases and Temporal Perception

NCT ID: NCT05874362

Last Updated: 2025-03-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

61 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-09-19

Study Completion Date

2026-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A violent death is defined by its brutality, unexpectedness and is secondary to an external cause (suicide, homicide, accident). Bereavement following a violent death constitutes a particular clinical situation, at risk of complications. Research on bereavement after a violent death shows higher risks of psychiatric and somatic complications than in bereavement by non-violent death. These complications, sometimes comorbid, take the form of depressive episodes, post-traumatic stress disorders, suicidal behavior and prolonged grief disorders after 12 months, precociously mediated by ruminations.

Processes responsible for this increased risk of complications are poorly documented. Current literature relates mainly to socio-demographic and epidemiological factors which, alone, do not explain this difference in risks. Further research is needed exploring other kinds of data and processes. To our knowledge, there is no description of early neurocognitive functioning in people bereaved after violent death. This study aims at exploring early neurocognitive processes which can lead to complications in people bereaved by violent death.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This work is based on cognitive models of post-traumatic stress disorder involving cognitive biases as factors of development and maintenance of symptomatology. Indeed, in people exposed to a potentially traumatic event, it has been found that an early deterioration in cognitive functioning is a risk factor for developing post-traumatic stress disorders . Among these cognitive alterations, attentional biases toward threat are the most explored and research shows both facilitated engagement and difficulties in disengagement in front of threatening stimuli. In addition, while expecting for a negative event, there is changes in the perception of time . These processes can be explored on a behavioral level and in electroencephalography , in particular through the evoked related potentials following a stimulus. Among these evoked related potentials , the Late Positive Potential component reflects the attentional process, while the Contingent Negative Variation component and the α and β power reflects temporal perception.

As exposure to violent death can have a traumatic impact, our hypothesis is that people bereaved by violent death could present attentional biases, and that these biases would be prodromal of the onset of a psychiatric disorder (Post-traumatic stress disorders , depression afterwards). The objective of this study is to describe the presence of these biases through electrophysiological and behavioral measures in a sample of subjects bereaved by violent death.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Post Traumatic Stress Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Subjects will be separated into two groups at the end of the study to conduct analyses, depending on the development of a psychiatric complication or not.
Primary Study Purpose

SCREENING

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group with complications at 3 month

Group composed with participants who develop a psychiatric complication (depressive episode or post traumatic stress disorder) 3 month after the death of their loved one.

Group Type OTHER

Diagnosis of depressive episode or post traumatic stress disorder

Intervention Type OTHER

Clinical diagnosis of depressive episode or post traumatic stress disorder, confirmed

Group without complication at 3 month

Group composed with participants who do not develop a psychiatric complication (depressive episode or post traumatic stress disorder) 3 month after the death of their loved one.

Group Type OTHER

No diagnosis of depressive episode or post traumatic stress disorder

Intervention Type OTHER

No elements in clinical assessment for the diagnosis of a depressive episode or post traumatic stress disorder

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Diagnosis of depressive episode or post traumatic stress disorder

Clinical diagnosis of depressive episode or post traumatic stress disorder, confirmed

Intervention Type OTHER

No diagnosis of depressive episode or post traumatic stress disorder

No elements in clinical assessment for the diagnosis of a depressive episode or post traumatic stress disorder

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* An age between 18 and 65 years old
* Recent bereavement by violent death of a relative in first and second degree

Exclusion Criteria

* Protected adults
* Lack of mastering French language
* History of neurodegenerative disorder
* History of psychiatric disorder treated pharmacologically with modification of the basic treatment in the month preceding the death
* The take of an benzodiazepine treatment in the 24th hours before the first visit (T0)
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hôpital le Vinatier

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Edouard LEAUNE

Role: PRINCIPAL_INVESTIGATOR

Vinatier Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hopital Vinatier

Bron, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Laurene LESTIENNE

Role: CONTACT

0033437915120

Véronique VIAL

Role: CONTACT

0033437915522

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

LEAUNE EDOUARD, Dr

Role: primary

+33437915120

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2023-A00304-41

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Diary for Severe Trauma
NCT02305303 COMPLETED NA
Recovering Sleep After Trauma
NCT07196332 NOT_YET_RECRUITING NA
Dissociation CBT Studies
NCT06054009 COMPLETED NA
Sleep and Wellbeing Study
NCT03012685 COMPLETED